• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2100074 古塞奇尤单抗注射液 guselkumab Lyophilized Biological Products Supplementary Application 2021-03-12 Janssen-Cilag International NV Janssen-Cilag International NV In Review 2021-03-12 view
JYHB2100105 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2021-02-02 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2021-03-09 view
JYSB2100002 古塞奇尤单抗注射液 guselkumab Lyophilized Biological Products Supplementary Application 2021-01-07 Janssen-Cilag International NV Janssen-Cilag International NV In Review 2021-01-06 view
JYSB2100003 古塞奇尤单抗注射液 guselkumab Lyophilized Biological Products Supplementary Application 2021-01-07 Janssen-Cilag International NV Janssen-Cilag International NV In Review 2021-01-06 view
JYHB2002636 棕榈酸帕利哌酮注射液 paliperidone palmitate Injection Chemical Drugs Supplementary Application 2020-12-21 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2021-01-14 view
JYHB2002635 棕榈酸帕利哌酮注射液 paliperidone palmitate Injection Chemical Drugs Supplementary Application 2020-12-21 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2021-01-14 view
JYHB2002637 棕榈酸帕利哌酮注射液 paliperidone palmitate Injection Chemical Drugs Supplementary Application 2020-12-21 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2021-01-14 view
JXSB2000044 Guselkumab注射液 guselkumab Lyophilized Biological Products Supplementary Application 2020-12-10 Janssen-Cilag International NV Janssen-Cilag International NV In Review 2020-12-09 view
JYSB2000583 乌司奴单抗注射液 ustekinumab Injection Biological Products Supplementary Application 2020-11-28 Janssen-Cilag International NV Janssen-Cilag International NV In Review 2020-11-27 view
JYSB2000581 乌司奴单抗注射液(静脉输注) ustekinumab Injection Biological Products Supplementary Application 2020-11-28 Janssen-Cilag International NV Janssen-Cilag International NV In Review 2020-11-27 view
JYSB2000584 乌司奴单抗注射液 ustekinumab Injection Biological Products Supplementary Application 2020-11-28 Janssen-Cilag International NV Janssen-Cilag International NV In Review 2020-11-27 view
JYSB2000533 乌司奴单抗注射液 ustekinumab Injection Biological Products Supplementary Application 2020-10-27 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2020-12-28 view
JYSB2000532 乌司奴单抗注射液 ustekinumab Injection Biological Products Supplementary Application 2020-10-27 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2020-12-28 view
JYSB2000531 乌司奴单抗注射液(静脉输注) ustekinumab Injection Biological Products Supplementary Application 2020-10-27 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2020-12-28 view
JYSB2000519 达雷妥尤单抗注射液 daratumumab Injection Biological Products Supplementary Application 2020-10-16 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2020-11-23 view
JYSB2000518 达雷妥尤单抗注射液 daratumumab Injection Biological Products Supplementary Application 2020-10-16 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2020-11-23 view
JYHB2001994 醋酸阿比特龙片 abiraterone acetate Tablet Chemical Drugs Supplementary Application 2020-10-14 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2020-12-21 view
JYSB2000513 古塞奇尤单抗注射液 guselkumab Lyophilized Biological Products Supplementary Application 2020-10-13 Janssen-Cilag International NV Janssen-Cilag International NV Filed 2020-10-21 view
JYSB2000489 乌司奴单抗注射液 ustekinumab Injection Biological Products Supplementary Application 2020-09-30 Janssen-Cilag International NV Janssen-Cilag International NV Filed 2020-10-30 view
JYSB2000488 乌司奴单抗注射液(静脉输注) ustekinumab Injection Biological Products Supplementary Application 2020-09-30 Janssen-Cilag International NV Janssen-Cilag International NV Filed 2020-10-30 view